From exceptionalism to normalisation: A reappraisal of attitudes and practice around HIV testing

British Medical Journal

Volumn 316, Issue 7127, 1998, Pages 290-293

  De Cock, Kevin M ^a   Johnson, Anne M ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EARLY DIAGNOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; UNITED KINGDOM; VERTICAL TRANSMISSION;

EID: 0032561935     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7127.290     Document Type: Short Survey

References (39)

1. Cohn JA. Recent advances: HIV infection - I. BMJ 1997;31:487-91.
2. Beiser C. Recent advances: HIV infection - II. BMJ 1997;314:579-83.
3. Bayer R. Public health policy and the AIDS epidemic. An end to HIV exceptionalism? N Engl J Med 1991;324:1500-4.
4. Schilts R. And the band played on: politics, people, and the AIDS epidemic. New York: St Martin's Press, 1987.
5. Wachter RM. AIDS, activism, and the politics of health. N Engl J Med 1991;326:128-33.
6. Berridge V. AIDS in the UK: The making of policy, 1981-1994. Oxford: Oxford University Press, 1996.
7. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
8. Wei X, Ghosh SK, Taylor MK, Johnson VA, Emini EA, Deutsch P. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
9. BHIVA Guidelines Co-ordinating Committee. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1997;349:1086-92.
10. Mellors JW, Rinalod CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
11. Carpenter CCJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA. Antiretroviral therapy for HIV infection in 1996. Recommendations of an International AIDS Society USA panel. JAMA 1996;276:146-54.
12. DELTA Co-ordinating Committee. DELTA: a randomized double blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine or zidovudine alone in HIV infected individuals. Lancet 1996;348:283-91.
13. Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, Schooley RT, Hanbrich RH. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996;335:1081-90.
14. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogies plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-33.
15. Kinloch-de Loes, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995;333:408-13.
16. Centers for Disease Control. Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR 1997;46:861-7.
17. Communicable Disease Surveillance Centre. Changes in the incidence of AIDS and in AIDS deaths: the effects of antiretroviral treatment. CDR 1997;7:381.
18. Connor EM, Sperling RS, Gelber R, Kiseler P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331: 1173-80.
19. Gibb DM, MacDonagh SE, Tookey PA, Duong T, Nicoll A, Goldberg DJ. Uptake of interventions to reduce mother-to-child transmission of HIV in the United Kingdom and Ireland. AIDS 1997;11:F53-8.
20. Miller D, Jeffries DJ, Green J, Harris JR, Pinching AJ. HTLV III: should testing ever be routine? BMJ 1986;292:941-3.
21. Birtwhistle K, Maguire H, Atkinson P, Carrington D. Who's having HIV tests? An audit of HIV test requests in a large London teaching hospital. Health Trends 1996;28:60-3.
22. Unlinked Anonymous HIV Seroprevalence Monitoring Programme England and Wales. Report from the Unlinked Anonymous Surveys Steering Group. Data to end 1995. London: Department of Health, 1996.
23. De Cock KM, Low N. HIV/AIDS, sexually transmitted diseases, and tuberculosis in ethnic minorities in the United Kingdom: is surveillance serving its purpose? BMJ 1997;314:1747-51.
24. Department of Health. Guidelines for offering voluntary named HIV antibody testing to women receiving antenatal care. London: Department of Health, 1994.
25. Centers for Disease Control. Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MWWR 1994;43(NoRR-11):1-20.
26. MacDonagh SE, Masters J, Helps BA, Tookey PA, Ades AE, Gibb DM. Descriptive survey of antenatal HIV testing in London: policy, uptake, and detection. BMJ 1996;313:532-3.
27. Stephenson JM, Griffioen A, Study Group for Medical Research Council Collaborative Study of Women with HIV. The effects of HIV diagnosis on reproductive experience. AIDS 1996;10:1688-7.
28. Meadows J, Jekinson S, Latalah J, Gazzard B. Voluntary HIV testing in the antenatal clinic: differing uptake rates for individual counselling midwives. AIDS Care 1990;2:229-33.
29. Blanche S, Mayaux MJ, Mandelbrot L, Rouzioux C, Delfraissy JF for the French Pediatric HIV Infection Study Group. Acceptability and impact of zidovudine prevention on mother to child HIV-1 transmission in France [abstract]. Fourth conference on retroviruses and opportunistic infections, Washington, DC, 22-26 January, 1997:A380.
30. Fiscus SA, Adimora AA, Schoenbach VJ, Lim W, McKinney R, Rupar D. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA 1996;275:1483-8.
31. Janssen RS, St Louis ME, Satten GA, Critchley SE, Petersen LR, Stafford RS. HIV infection among patients in US acute care hospitals. Strategies for the counselling and testing of hospital patients. N Engl J Med 1992; 327:445-52.
32. Bor R, Lipman M, Elford J, Murray D, Miller R, Griffiths P. HIV seroprevalence in a London same-day testing clinic. AIDS 1994;8:697-700.
33. Schopper D, Vercauteren G. Testing for HIV at home: what are the issues? AIDS 1996;13:1455-05.
34. Merson MH, Feldman EA, Bayer R, Stryker J. Rapid self testing for HIV infection. Lancet 1997;349:352-3.
35. Oakley A, Fullerton D, Holland J. Behavioural interventions for HIV/AIDS prevention. AIDS 1995;9:479-86.
36. De Vincenzi I, the European Study Group on Heterosexual Transmission of HIV. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1994;331:341-6.
37. Zenilman JM, Erickson B, Fox R, Reichart CA, Hook EW. Effect of HIV post test counselling on STD incidence. JAMA 1992;267:843-5.
38. Miller R, Lipman M. HIV pretest discussion. BMJ 1996;313:130.
39. Temmerman M, Ndinya-Achola J, Ambani J, Piot P. The right not to know HIV test results. Lancet 1995;345:1506-7.